tweetindex
ID

Scott Gottlieb, MD 🇺🇸

@ScottGottliebMD · Washington, DC · joined 15 May 2009

Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd Commissioner of the @US_FDA. Public Boards: @Pfizer @Illumina @TempusAI @UnitedHealthGrp

530 038Followers
4 681Following
23 082Posts total
797KViews on collected posts

Postingan terbaru

🧵More vaccines do not mean more distinct antigens. The childhood vaccine schedule contained 3,217 antigenic components in 1960 and 3,041 by the 1980s. Today, owing to better formulations, it's about 165 antigens across the current pediatric schedule 1/2 https://t.co/xc06FHWrtb 140.9K views · 550 likes · 180 reposts · 1 replies Open on X →
📝This is an important reform. FDA has generally lacked sufficient authority to meaningfully regulate these substances; and that lack of authority has stymied similar actions in the past. In this proposed rule, the agency appears to have gone as far as it can, without new 166K views · 78 likes · 28 reposts · 1 replies Open on X →
1/2 This is a large number of cases over a short period, and the count may still rise. It's at least the 2nd major outbreak this year linked to produce from a distinct Mexican growing region—jalapeños from Sinaloa after iceberg lettuce from central Mexico https://t.co/GXvKk1UxY1 150.2K views · 149 likes · 41 reposts · 3 replies Open on X →
FDA has done an effective job tracing much of this outbreak back to growing regions in central Mexico and specific farms. There are steps consumers can take to further mitigate risk. Retailers and restaurants with good supply chain management have shifted their purchasing. People 194.5K views · 143 likes · 30 reposts · 1 replies Open on X →
My segment on @SquawkCNBC on cyclospora in bagged lettuce and FDA’s effort to trace cases to a grower in Mexico and isolate the root cause of the outbreak. Discussed steps consumers can take. FDA’s ongoing oversight should mitigate risks. @AEI https://t.co/g14J5W93QO 145.3K views · 74 likes · 10 reposts · 13 replies Open on X →

Dibandingkan akun berukuran sama

5 postingan dari 90 hari terakhir, dibandingkan dengan rentang 100K–1M pengikut. tampil luas, tetapi sedikit penonton yang merespons.

Median tayangan150 176akun ini4 254median untuk 100K–1M
Jangkauan, %28.33%akun ini1.66%median untuk 100K–1M
Interaksi, %0.09%akun ini1.34%median untuk 100K–1M
MetrikAkun iniMedian untuk 100K–1MRasio
Median tayangan per postingan150 1764 25435.3×
Jangkauan (tayangan ÷ pengikut)28.33%1.66%17.1×
Tingkat interaksi0.09%1.34%0.07×

Akun lain pada rentang ini →   Bandingkan dengan akun lain →   Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

145.3K21 Jul
194.5K26 Jul
150.2K7 Aug
166K10 Aug
140.9K11 Aug

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.07%21 Jul
0.09%26 Jul
0.13%7 Aug
0.06%10 Aug
0.52%11 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.34%.

What the audience does

Likes67.3%994 in total
Reposts19.6%289 in total
Replies1.3%19 in total
Bookmarks11.8%174 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Akun serupa